Cargando…

Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis

BACKGROUND: The purpose of this prospective, open-label, observational study was to assess the fracture preventing effect of Maxmarvil® tablets (alendronate 5 mg + calcitriol 0.5 µg) in patients with osteoporosis and to evaluate the change in bone mineral density (BMD) at the minimum 1-year follow-u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Jun-Il, Ha, Yong-Chan, Won, Ye-Yeon, Yang, Kyu-Hyun, Kim, Sang-Bum, Yoo, Ju-Hyung, Kim, Dong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Bone and Mineral Research 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472803/ https://www.ncbi.nlm.nih.gov/pubmed/28642852 http://dx.doi.org/10.11005/jbm.2017.24.2.91

Ejemplares similares

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
por: Hiligsmann, M., et al.
Publicado: (2021)

Comparative Evaluation of Intrathecal Bupivacaine 0.5% With Intrathecal Bupivacaine 0.5% and 60-µg Buprenorphine for Postoperative Analgesia in Elective Cesarean Section Patients
por: Shrinivas, T. R., et al.
Publicado: (2022)

Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
por: Casado, Enrique, et al.
Publicado: (2023)

Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats
por: Nakamura, Yoshinari, et al.
Publicado: (2008)

Crystal chemistry and compressibility of Fe(0.5)Mg(0.5)Al(0.5)Si(0.5)O(3) and FeMg(0.5)Si(0.5)O(3) silicate perovskites at pressures up to 95 GPa
por: Koemets, Iuliia, et al.
Publicado: (2023)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
por: Zhang, Z. L., et al.
Publicado: (2015)

Li(0.5)Al(0.5)Mg(2)(MoO(4))(3)
por: Ennajeh, Ines, et al.
Publicado: (2013)

Erratum to: Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
por: Zhang, Z. L., et al.
Publicado: (2015)

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
por: Nakamura, Toshitaka, et al.
Publicado: (2013)

Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Preparation and Characterization of Mg–Al–B Alloy (Mg(0.5)Al(0.5)B(2)) Via High-Temperature Sintering
por: Yang, Lin, et al.
Publicado: (2021)

Annealing-Dependent Morphotropic Phase Boundary in the BiMg(0.5)Ti(0.5)O(3)–BiZn(0.5)Ti(0.5)O(3) Perovskite System
por: Cardoso, João Pedro V., et al.
Publicado: (2022)

Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax(®) tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study
por: Zhang, Yifan, et al.
Publicado: (2017)

Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen
por: Yoo, Seul Gi, et al.
Publicado: (2017)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Characterization and Properties of Mg-xGd-1.5Nd-0.5Zn-0.5Zr Alloys for Biodegradation Applications
por: Gui, Zhenzhen, et al.
Publicado: (2020)

Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination
por: Kim, Hyun Chul, et al.
Publicado: (2022)

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
por: Mori, Satoshi, et al.
Publicado: (2022)

Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 µg in Healthy Japanese Volunteers
por: Darwish, Mona, et al.
Publicado: (2008)

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions
por: Wu, Lihua, et al.
Publicado: (2019)

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
por: Dahlöf, Carl, et al.
Publicado: (2004)

Hot Deformation Behavior, Processing Maps and Microstructural Evolution of the Mg-2.5Nd-0.5Zn-0.5Zr Alloy
por: Ma, Junfei, et al.
Publicado: (2022)

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
por: Ramos, Mafalda, et al.
Publicado: (2016)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
por: Ahn, Guk Young, et al.
Publicado: (2021)

Surface Modification of Biomedical MgCa(4.5) and MgCa(4.5)Gd(0.5) Alloys by Micro-Arc Oxidation
por: Sakiewicz, Piotr, et al.
Publicado: (2021)

Grain Growth Behavior and Electrical Properties of 0.96(K(0.46−x)Na(0.54−x))Nb(0.95)Sb(0.05)O(3)–0.04Bi(0.5)(Na(0.82)K(0.18))(0.5)ZrO(3) Ceramics
por: Park, Yeon-Ju, et al.
Publicado: (2022)

Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review
por: Liao, Ruo-xi, et al.
Publicado: (2014)

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Preanesthetic dexmedetomidine 1 µg/kg single infusion is a simple, easy, and economic adjuvant for general anesthesia
por: Shin, Hye Won, et al.
Publicado: (2013)

Annealing Temperature Effects on Humidity Sensor Properties for Mg(0.5)W(0.5)Fe(2)O(4) Spinel Ferrite
por: Petrila, Iulian, et al.
Publicado: (2022)

Effect of Process Temperature on Density and Electrical Characteristics of Hf(0.5)Zr(0.5)O(2) Thin Films Prepared by Plasma-Enhanced Atomic Layer Deposition
por: Kim, Hak-Gyeong, et al.
Publicado: (2022)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Bioequivalence of Alendronate and Vitamin D(3) in a Combination Tablet Versus Corresponding-Dose Individual Tablets in Healthy Taiwanese Volunteers, Determined Using a Novel Plasma Alendronate Assay
por: Wright, D. Hamish, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2omptmlpbvuth8kdfsc4bsmuaa